Business case

Build your business case
with evidence you can cite.

The benefits, evidence, obligations, costs and assurances for Clinical Branches, each labelled with its source and the roles it matters to, ready to adapt for your internal submission.

Request the business case pack

77

hospitals live across Australia and Canada

20.8 pts

improvement in prescribing appropriateness where adopted, in the WACHS and UTS evaluation

21.8 pts

improvement in guideline compliance where adopted, in the WACHS and UTS evaluation

48.1s

average time to complete a pathway, platform data

Joint evaluation of the platform by the WA Country Health Service (WACHS) and the University of Technology Sydney (UTS), funded by the Digital Health Cooperative Research Centre (DHCRC-0248). Prescribing was compared before and after implementation in a balanced sample of three adopter and five non-adopter hospitals, and the estimates describe an effect observed where the platform was adopted. WACHS deploys the platform as AMPS. Read the evaluation snapshot (PDF).

Safety and quality

Better prescribing decisions at the point of care, and patients at risk identified before harm occurs.

More appropriate prescribing

A 20.8 percentage point improvement in the probability of an appropriate prescription where the platform was adopted, in the evaluation's preferred model adjusted for patient, workforce, occupancy, hospital and time effects.

Higher guideline compliance

A 21.8 percentage point improvement in guideline compliance where adopted, across a balanced sample of three adopter and five non-adopter hospitals.

Better emergency telehealth prescribing

Optimal antimicrobial prescribing at the WACHS Emergency Telehealth Service rose from 28% to 68%, and inadequate prescribing fell from 22% to 4%, across three NAPS-defined audit periods alongside pharmacist-led education.

Reduced broad-spectrum antimicrobial use

At a regional NSW hospital, ceftriaxone use fell by 69%, from about 128 to 40 defined daily doses per 1,000 occupied bed days, over a 12-month virtual stewardship programme that used Clinical Branches to review every patient on an antimicrobial. Read the conference poster (PDF).

Recommendations acted on more often

In the same programme, uptake of stewardship recommendations rose from below 45% to above 65% over twelve months, as reviewing every antimicrobial built rapport with the medical and surgical teams. Read the conference poster (PDF).

Patients at risk of hospital-acquired complications flagged

Hints screen every patient for risks such as medication harm, duplicated therapy, doses unsuited to renal function and inappropriate antimicrobial use. Each service selects its hints from a shared library of thousands.

Vancomycin AUC dosing from a single level

Bayesian AUC dosing from a single level, validated against two patient cohort reference sets, synthetic data and clinician feedback, and presented at Medicines Management 2025. Available to sites participating in testing while TGA Class IIb conformity assessment is underway. Read the validation poster (PDF).

Safer transitions of care

Reconciliation produces a patient-friendly medication list and a medication management plan shared with the next site of care, with alerts for medicines omitted at discharge.

Workforce and efficiency

Clinician and pharmacist time directed to where it matters, with less duplicated documentation.

Decisions in under a minute

Pathways take 48.1 seconds on average to complete, on web or on the native iOS and Android apps, online or offline.

Specialist-informed guidance where specialist advice is hard to reach

In the joint WACHS and UTS evaluation, clinicians valued the platform most when infectious diseases advice was difficult to access, giving them specialist-informed guidance to confirm and structure their decisions.

Pharmacist time directed to the highest-risk patients

The pharmacy and stewardship ward lists rank patients by the hints each service enables, with completed care and risk-banded interventions in view.

Prompts clinicians find useful

In a 12-month virtual stewardship programme at Far West Local Health District that reviewed every patient on an antimicrobial, 84% of 2,214 hints were rated useful by the reviewing pharmacists. Every hint carries a usefulness rating, so low-value rules can be refined or retired. Read the conference poster (PDF).

Documentation as a by-product of care

Seeking guidance creates the record of assessment, audit entries and follow-up tasks, so clinicians do not document the same decision twice. At pilot sites, mobile scribing captures medication histories at the bedside.

Governance and accreditation

A quality improvement cycle that records its own evidence, with content under version control.

Accreditation evidence from routine care

Decisions, audits and hint responses are mapped to NSQHS Standards 1, 3 and 4 and the ACSQHC antimicrobial stewardship quality indicators, captured during routine care rather than sampled retrospectively.Decisions, audits and hint responses become evidence for antimicrobial stewardship and medication safety Required Organizational Practices, captured during routine care rather than sampled retrospectively.

Quality improvement cycles benchmarked against peers

KPI dashboards and the decision heat map compare your service with peer groups when both opt in, and each procedure change is recorded with version, author and reviewer.

Product capability

Content that stays current

Every pathway is checked nightly against its source guideline, with changes flagged for review against the pathway recommendations. A built-in governance cycle ensures peer review and approval of all clinical content, and each decision records the pathway version used.

Continuous appropriateness audit

Appropriateness is recorded during review, in established categories, replacing the annual sampled audit campaign.

Traceable restricted antimicrobial approvals

Every approval code issued through the platform carries an explicit clinical justification, under your local policy.

Visibility and analytics

Practice, patient risk and service activity visible across every site, from routine decisions rather than sampled audits.

Unwarranted variation identified

The decision heat map shows how often each branch is taken by site, region and patient cohort, separating warranted from unwarranted variation to target education.

Patient outcomes linked to guidelines

Length of stay, readmission and risk of hospital admission are linked to each decision path and patient cohort, on a dashboard with data export.

The value of the pharmacy service

Pharmacy dashboards report histories, reconciliations, patients without recent review, and interventions by ward, team and pharmacist.

Product capability

Stewardship reporting across domains

Dashboards for antimicrobial, opioid and VTE stewardship, including oral morphine equivalents, naloxone use and VTE assessment within 24 hours.

Implementation and delivery risk

A managed service that goes live quickly, with little effort asked of clinical teams.

Guidelines converted with little effort from your team

Your complete set of guidelines and procedures is converted into draft pathways and decision support rules for clinician review. For one remote nursing program, our team built 86 primary care pathways in about 120 hours, with clinician review.

Live in two to six months

Environment, configuration and single sign-on in four to eight weeks, while your clinicians review the converted content, then onboarding in two to four weeks per site group.

One codebase, configured for you

Your pathways, hints and settings are configuration, not custom code. The identical codebase runs across all deployments, so every service receives each improvement.

Low data dependency

Only the patient identifier and location are mandatory, so decision support runs at sites with limited integration, including paper-based sites and offline on mobile.

Go-live protected from integration delays

Fallback paths keep the project moving, such as a manual ward list while HL7 feeds are completed. Operates alongside Epic, Cerner, MedChart and iCM.

Product capability

Over 99.99% uptime

A single five-minute outage in three years of operation, on redundant infrastructure with automated backup, and zero-downtime releases.

Platform data

Obligations it helps you meet

The standards most business cases are written against.

NSQHS Standard 1: Clinical Governance

Action 1.27 evidence-based care and action 1.28 variation in practice, through pathways, version control and the decision heat map.

NSQHS Standard 3: Antimicrobial stewardship

Actions 3.18 and 3.19, with continuous appropriateness audit aligned to the ACSQHC antimicrobial stewardship quality indicators.

NSQHS Standard 4: Medication Safety

Medication reconciliation, best possible medication history and high-risk medicines under action 4.15, including anticoagulants and opioids.

Clinical care standards

Opioid Analgesic Stewardship in Acute Pain and VTE Prevention clinical care standards, through dashboards, hints and audit.

View the full standards and evidence mapping

Antimicrobial stewardship Required Organizational Practice

Evidence from routine prescribing decisions, prioritised review and continuous appropriateness audit.

Medication reconciliation and safety

Best possible medication history, reconciliation and patient-friendly medication lists at transitions of care.

Costs and commercial terms

Predictable licensing, with the costs a finance team will ask about set out in advance.

Per-bed annual subscription

Licensed per bed, per year (per clinic for community sites), so cost scales with the size of each site rather than with use. No per-user, per-transaction or per-alert charges.

Upgrades, support and hosting included

Hosting, maintenance, security patching, all releases and upgrades, updates to the shared content library, support and training are included in the licence.

Commercial terms

Fixed-fee implementation

Implementation is a one-off fixed fee, which can be tied to delivery milestones, and is reduced where integrations such as single sign-on already exist.

Commercial terms

One licence for a whole network

Statewide and network agreements are priced as a single licence, with unified data and new sites added by configuration rather than new contracts.

Commercial terms

A break-even prepared for you

For a typical regional site, the annual licence breaks even at about one hour of pharmacist or clinician time released per week. Our team prepares the analysis against your bed numbers and staffing costs.

No lock-in

Data, metadata and configuration are returned at no charge in an open format, with certified destruction and service continuity through any transition.

Commercial terms

View plans and pricing

Security, regulatory and supplier assurance

The documentation ICT, privacy, procurement and risk teams will ask for.

Certified information security

ISO 27001:2022 and ISO 27017:2015 certified, from a JAS-ANZ accredited certifier, with annual independent penetration testing.

Supplier assurance

Data held in-country

Australian-owned and hosted in AWS Sydney, with no offshore access, and separate database partitions for each jurisdiction.Canadian data held in Canada, on infrastructure separate from the Australian service.

Supplier assurance

Regulatory status

Decision support functions are supplied under the TGA exemption for clinical decision support software. The vancomycin AUC calculator is undergoing TGA Class IIb conformity assessment and is available only to sites participating in testing until it is included in the ARTG. The post-market record shows no reportable adverse events, recalls or data breaches since November 2022.The platform carries no software as a medical device function in Canada and is exempt from Health Canada medical device licensing.

Supplier assurance

Clinical judgement stays with the clinician

Clinical Branches supports clinical judgement rather than replacing it, and has never modified a medication order inside any EMR.

Supplier assurance

An independent supplier

No pharmaceutical relationships, and revenue only from health services, so there is no commercial interest in increasing medicine use.

Supplier assurance

Published shared responsibilities

A shared responsibilities matrix and device information are published for review before procurement.

Supplier assurance

Evidence register

Where each figure comes from, so it can be cited at the right strength.

WACHS and UTS evaluation
WACHS and UTS evaluation (DHCRC-0248)
Joint evaluation of the platform before and after implementation by the WA Country Health Service and the University of Technology Sydney, funded by the Digital Health Cooperative Research Centre. 3,917 audited prescriptions across three adopter and five non-adopter hospitals, usage data from 68 health services and 30 clinician interviews. Results describe effects observed where the platform was adopted. WACHS deploys the platform as AMPS. Read the evaluation snapshot (PDF).
Validation study
Vancomycin AUC validation
Validation against two patient cohort reference sets, synthetic data and clinician feedback, with patient data used under HREC approval. Presented at Medicines Management 2025. Read the validation poster (PDF).
Local audit
WACHS Emergency Telehealth Service audit
Local prospective audit by WACHS clinicians across three NAPS-defined audit periods, alongside pharmacist-led education.
Local audit
Far West Local Health District hint evaluation
Local evaluation of 2,214 hints rated by pharmacists over 12 months, presented at the SHPA Medicines Management conference. RAPA, named in the poster, is the audit tool within Clinical Branches. Read the conference poster (PDF).
Programme result
Regional NSW stewardship programme
Twelve months of data from a virtual stewardship programme at a regional NSW hospital, reviewing every patient on an antimicrobial with Clinical Branches. Read the conference poster (PDF).
Platform data
Platform data
Telemetry and delivery records from live deployments, including pathway completion time, uptime and implementation timelines.
Product capability
Product capability
Functions available in the current release, demonstrable on request.
Commercial terms
Commercial terms
Standard licensing and contract terms. Specific pricing is provided on request.
Supplier assurance
Supplier assurance
Certifications, hosting, regulatory and supplier records, provided in the business case pack and on request.